Michael John Kazley - Chief Executive Officer, Director, 10%+ Owner at NovaBay Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director, 10%+ Owner
Issuer Symbol
NBY on NYSE
All Insider Reports
All Insider Reports

Sponsored

There are no Buy or Sell transactions made by Michael John Kazley since 08 Apr 2025

Holdings reported by Michael John Kazley for NovaBay Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 56,806,080 $74,228,504 $1.31 21 Oct 2025 By R01 Entities
Restricted Stock Units (Performance-Based) 7,722,802 31 Mar 2026 Direct Common Stock
Restricted Stock Units (Time-Based) 4,118,828 31 Mar 2026 Direct Common Stock
Pre-Funded Warrants (Right to Buy) 2,702,703 16 Oct 2025 By R01 Entities Common Stock
Series D Non-Voting Convertible Preferred Stock 220,663 16 Oct 2025 By R01 Entities Common Stock
Series E Non-Voting Convertible Preferred Stock 134,375 16 Oct 2025 By R01 Entities Common Stock

Transactions reported by Michael John Kazley for NovaBay Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored